The pharmaceutical landscape for glucose is evolving, and transdermal GLP-1 delivery systems represent a potential advance. Unlike injections, this method offers a less invasive way to provide GLP-1 therapies. These https://andrewuucc162615.tusblogos.com/41593608/glp-1-patches-a-innovative-approach-to-diabetes-management